Susquehanna International Group, LLP Crinetics Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$42.12 - $51.91 $2.06 Million - $2.54 Million	-48,900 Reduced 84.75%	8,800 $394,000
Q1 2024 May 07, 2024	BUY	$34.76 - $46.81 $1.13 Million - $1.52 Million	32,500 Added 128.97%	57,700 $2.7 Million
Q4 2023 Feb 14, 2024	SELL	$25.62 - $37.07 $163,968 - $237,248	-6,400 Reduced 20.25%	25,200 $896,000
Q3 2023 Nov 14, 2023	BUY	$15.97 - $30.59 $236,356 - $452,732	14,800 Added 88.1%	31,600 $939,000
Q2 2023 Aug 11, 2023	BUY	$15.73 - $23.6 $264,264 - $396,480	16,800 New	16,800 $302,000

244

78.2M

268K

197K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.73B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.